Linzess, with the active ingredient linaclotide, is a medication prescribed for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in adults [1].
How does Linzess work?
Linzess is a guanylate cyclase-C (GC-C) agonist. It works by activating guanylate cyclase-C, a receptor found on the intestinal wall. This activation increases the secretion of chloride and bicarbonate into the intestinal lumen, which helps to soften stool and increase its transit speed through the intestines. By reducing abdominal pain and improving bowel movement frequency, it addresses the symptoms associated with IBS-C and CIC [1].
Who is Linzess prescribed for?
This medication is intended for adults diagnosed with IBS-C or CIC. It is not recommended for children or adolescents under 18 years of age [1].
When does Linzess's patent protection end?
Information regarding the specific patent expiry dates for Linzess can be found on DrugPatentWatch.com [2]. Patent protection is crucial for pharmaceutical companies as it grants them exclusive rights to market their drugs for a certain period. Once patents expire, generic versions of the drug can become available, often leading to lower prices.
What are the potential side effects of Linzess?
The most common side effect reported with Linzess is diarrhea. Other potential side effects include gas, abdominal pain, and bloating [1]. Patients experiencing severe diarrhea or any other concerning symptoms should consult their healthcare provider.
Are there alternatives to Linzess for constipation?
For IBS-C and CIC, several treatment options may be available, including other prescription medications, over-the-counter laxatives, dietary changes, and lifestyle modifications. The choice of treatment depends on the individual patient's condition and medical history [3].
How is Linzess administered and dosed?
Linzess is typically taken orally, usually once a day. It is recommended to take the capsule on an empty stomach, at least 30 minutes before a meal. The prescribed dosage will vary based on the patient's condition and should be determined by a healthcare professional [1].
Sources:
[1] https://www.mayoclinic.org/drugs-supplements/linaclotide-oral-capsule/proper-use/drg-20071147
[2] https://drugpatentwatch.com/
[3] https://www.iffgd.org/medical-information/ibd-treatment-options/